Dr. Aditi Aggarwal

Dr. Aditi Aggarwal

Verified
Senior Consultant
  • Radiation Oncologist
MBBS, MD
Experience
14 yrs
AboutEducationAwardsSimilar doctorsFAQ

About Dr. Aditi Aggarwal

  • Dr. Aditi Aggarwal is a radiation oncologist with an extensive experience of more than 10 years.
  • She has received specialized training in advanced techniques such as IMRT, IGRT, SRS, SBRT, and SRT.
  • She has been involved in various research projects at Tata Memorial Hospital and has special interest in Gynecological, Brain and Head Neck and Gastrointestinal Tumors and Sarcomas.
  • She has worked at the best institutes of the country such as Tata Memorial Hospital, Mumbai, and AIIMS Hospital, Jhajjar.
  • She is a member of institutions like Faculty National Cancer Institute, AIIMS, Senior Research Associate at MAMC and LNJP Hospital, Delhi, Associate Consultant at IOSPL, Fortis Noida, and Senior Resident at Tata Memorial Hospital.


 

  • VerifiedMBBS, Lady Hardinge Medical College, Delhi
  • VerifiedMD, VMMC and Safdarjang Hospital, Delhi (Delhi University)
  • VerifiedFellowship, Fellowship, Catalyst Clinical Sciences, Pune

Papers Published

  • Comparitive study of
    efficacy, tolerability of four field box technique vs. two field anterior
    posterior technique in locally advanced carcinoma cervix: A prospective
    analysis.. Cancer Biology and Therapy. 05/2009; 8:9, 759-764.
+ Read More
  • Clinical Outcome of Early-Stage Endometroid
    Adenocarcinoma: A Tertiary Cancer Center Experience. International Journal
    of Gynecological Cancer .10/2013; 23(8):1446-1452.
  • Evaluation of Internal Target Volume in patients undergoing
    Image Guided Intensity Modulated adjuvant radiation for gastric cancers.
    British Journal of Radiology. 11/2013; 10/1259.
  • Acute Toxicity And Compliance With Tomotherapy Based
    Adjuvant Intensity Modulated Radiotherapy In Patients With Gastric Cancer:
    Results From Prospective Study. Annals of Oncology. 2013; 24(4):iv63.
  • IMRT is not superior to 3DCRT
    for adjuvant gastric cancer radiation: A matched pair analysis.
    JCRT.10/2015;11(3): 623-629.
  • Impact of Oligodendroglial component in Glioblastoma (GBM-O): Is the
    outcome favourable than Glioblastoma?. Clinical Neurology and
    Neusosurgery. 8/2015; 135: 46-53.
  •  Antiemetic Trials in
    Oncology: What should be done next? Natl Med J India. 29(2).Mar-Apr 2016.
  • Adaptive
    Radiotherapy: A hybrid (on-line image guidance + off-line adaptive)
    approach for head and neck cancer. Poster in ESTRO 2016
  • Organization of Chemotherapy and
    Systemic Therapy Services in India: Devil lies in details. Journal of Global
    Oncology. 2017 ;3(2): 182-183.
  • Discordance of histo-pathological
    diagnosis of patients with soft tissue sarcoma referred to tertiary care center.
    Journal of Clinical Oncology. 2017 35:15_suppl, 11064-11064.
  • IlavarasiVanidassane et al Pazopanib
    toxicity in a metastatic sarcoma cohort : Are Indian patients different?. Annals
    of Oncology (2017) 28 (suppl_10): x149-x152. 10.1093/annonc/mdx675.
  • Cardiovascular Disease Burden in Cancer Patients from
    2003 to 2014. European Heart Journal – Quality of Care and Clinical
    Outcomes, 2017;4(1): 69–70.
  • Fate of incidental gall bladder cancers: A single
    centre experience.,. E-poster presented at ICC 2017.
  • Chemotherapy in non metastatic osteosarcoma: Recent advances and
    implication for developing countries. Journal of Global Oncology. 2018; 4: 1-5.
  • Adding olanzapine to
    three drugs anti emetic regimen: Is it time to jump the gun? IJMPO 3/2018;
    39 (2):125.
  • IlavarasiVanidassaneGeddis Trial
    and Its Primary End PointThere is An Elephant in the Room! Clin Oncol.
    2018; 3: 1414.
  •  Retrospective analysis of management and
    outcome of advanced soft tissue sarcomas (STS) with rare histology.. J Clin
    Oncol 36, 2018 (suppl; abstr e23564)
  • Outcomes of advanced soft tissue
    sarcoma from dedicated medical oncology sarcoma clinic in North India and
    evaluation of the respective model. J Clin Oncol 36, 2018 (suppl; abstr
    e23561)
  • The quest for histology
    driven neoadjuvant chemotherapy in soft tissue sarcoma: end of road or just
    the beginning? Epub ahead of Print.2018
  • Advanced dermatofibrosarcoma protuberans
    treatment with imatinib – Experience from dedicated sarcoma medical
    oncology clinic in India . Accepted for publication in JGO June 2018
  •  Accepted in
    Indian Journal of Cancer
  • Study of effects of Dwell Time Deviation
    Constraints on Inverse planning simulated annealing optimized plans of
    intracavitary brachytherapy of carcinoma cervix. JCRT. Epub ahead of print
    2018
  • Management of Gynaecological malignancies- A case based approach.
    Chapter in Textbook of Obstetrics and Gynaecology. A K Rathi, Aditi
    Aggarwal. 2018

Send Your Enquiry

Fill in your details and our medical experts will contact you within 24 hours.

By submitting I agree to the Terms of Use and Privacy Policy of Vaidam Health.

Want to consult the doctor?

Don't Ignore Your Health!

Other Top Radiation Oncologist In Gurgaon

Dr. Subodh Chandra Pande

Dr. Subodh Chandra Pande

5.0 (32 Ratings)
Radiation Oncologist
Artemis Hospital, Gurgaon · Gurgaon
47+ years of experience
Chat IconChat
Dr. S. Jayalakshmi

Dr. S. Jayalakshmi

Radiation Oncologist
Artemis Hospital, Gurgaon · Gurgaon
26+ years of experience
Chat IconChat
Dr. Bidhu K Mohanti

Dr. Bidhu K Mohanti

5.0 (51 Ratings)
Radiation Oncologist
Gurgaon
40+ years of experience
Chat IconChat
Dr. Tejinder Kataria

Dr. Tejinder Kataria

Radiation Oncologist
Medanta - The Medicity, Gurgaon · Gurgaon
36+ years of experience
Chat IconChat

FAQ's About Dr. Aditi Aggarwal

What is the specialty of Dr. Aditi Aggarwal?

Dr. Aditi Aggarwal specialty is Radiation Oncologist

What is the experience of Dr. Aditi Aggarwal?

Dr. Aditi Aggarwal is Radiation Oncologist with 14 years of experience.

Our Network

500+

Top Hospitals

10,000+

Doctors

50+

Cities

10+

Countries

Need Assistance?Chat